4//SEC Filing
Tardio Jason 4
Accession 0001209191-21-044391
CIK 0001636651other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:23 PM ET
Size
5.4 KB
Accession
0001209191-21-044391
Insider Transaction Report
Form 4
Tardio Jason
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-07-01+50,000→ 50,000 totalExercise: $3.95Exp: 2031-06-30→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the Stock Option will vest and become exercisable on July 1, 2022 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001794698
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 4:23 PM ET
- Size
- 5.4 KB